RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $130,600 | -33.1% | 101,240 | -31.6% | 0.00% | 0.0% |
| Q1 2023 | $195,361 | -52.2% | 148,001 | -45.7% | 0.00% | -50.0% |
| Q4 2022 | $408,708 | +104.4% | 272,472 | +60.6% | 0.00% | +100.0% |
| Q3 2022 | $200,000 | +138.1% | 169,703 | +127.3% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | +52.7% | 74,675 | +308.2% | 0.00% | – |
| Q1 2022 | $55,000 | -1.8% | 18,295 | -12.9% | 0.00% | -100.0% |
| Q4 2021 | $56,000 | +133.3% | 21,000 | +217.6% | 0.00% | – |
| Q3 2021 | $24,000 | -80.6% | 6,612 | -81.7% | 0.00% | -100.0% |
| Q1 2021 | $124,000 | +33.3% | 36,148 | +36.6% | 0.00% | +100.0% |
| Q4 2020 | $93,000 | -31.1% | 26,471 | -53.0% | 0.00% | -50.0% |
| Q3 2020 | $135,000 | +92.9% | 56,292 | +51.4% | 0.00% | +100.0% |
| Q3 2019 | $70,000 | +118.8% | 37,193 | +206.9% | 0.00% | 0.0% |
| Q2 2019 | $32,000 | -83.2% | 12,117 | -83.6% | 0.00% | -83.3% |
| Q1 2019 | $190,000 | -2.1% | 73,986 | -12.5% | 0.01% | -33.3% |
| Q4 2018 | $194,000 | +185.3% | 84,520 | +299.5% | 0.01% | +125.0% |
| Q3 2018 | $68,000 | -60.2% | 21,159 | -65.1% | 0.00% | -55.6% |
| Q2 2018 | $171,000 | +140.8% | 60,559 | +199.9% | 0.01% | +125.0% |
| Q1 2018 | $71,000 | -24.5% | 20,193 | -45.4% | 0.00% | -20.0% |
| Q3 2017 | $94,000 | +91.8% | 36,986 | +79.8% | 0.01% | +25.0% |
| Q4 2016 | $49,000 | -58.1% | 20,571 | -35.7% | 0.00% | -50.0% |
| Q3 2016 | $117,000 | +317.9% | 32,014 | +137.1% | 0.01% | +300.0% |
| Q1 2016 | $28,000 | -36.4% | 13,503 | -25.0% | 0.00% | 0.0% |
| Q3 2015 | $44,000 | -44.3% | 18,007 | -18.7% | 0.00% | -50.0% |
| Q1 2015 | $79,000 | – | 22,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |